Ceftriaxone IV Dosing in Dialysis
For patients on hemodialysis, administer ceftriaxone 2 grams IV immediately after each dialysis session, with no supplemental dosing required during or between dialysis sessions. 1, 2
Standard Dosing Regimen for Hemodialysis Patients
The FDA-approved dosing states that no dosage adjustment is necessary for patients with renal impairment, and ceftriaxone is not removed by peritoneal- or hemodialysis, with no additional supplementary dosing required following dialysis. 1
For patients with both severe renal and hepatic dysfunction, the maximum daily dose should not exceed 2 grams, with close clinical monitoring for safety and efficacy. 1
Ceftriaxone 2 grams IV administered immediately after dialysis maintains therapeutic concentrations throughout the 48-72 hour interdialysis period for most infections. 2
Pharmacokinetic Rationale
The elimination half-life of ceftriaxone is prolonged to approximately 14-17 hours in hemodialysis patients (compared to 5.8-8.7 hours in patients with normal renal function), allowing for extended dosing intervals. 1, 2, 3, 4, 5, 6
Hemodialysis removes approximately 41% of ceftriaxone over a 4-hour session, but plasma concentrations remain within the therapeutic range (40.4 ± 4.7 mcg/mL) at the end of dialysis. 5
The plasma clearance of ceftriaxone in hemodialysis patients is 0.36-0.40 L/h during the interdialysis period, compared to 0.58-1.45 L/h in patients with normal renal function. 2, 3, 5
Dosing Algorithm by Infection Severity
Standard Infections (UTI, Pneumonia, Skin/Soft Tissue)
Administer ceftriaxone 1 gram IV after each dialysis session (every 48 hours) for uncomplicated infections when the pathogen MIC is ≤1 mg/L. 2, 3
For infections with pathogens having MIC values of 1 mg/L, the median free drug concentration at 48 hours is 1.11 mg/L (range 0.63-1.89 mg/L), maintaining adequate coverage. 2
Severe Infections or Resistant Organisms
Administer ceftriaxone 2 grams IV after each dialysis session for severe infections or when the pathogen MIC is >1 mg/L or unknown. 2, 6
For pathogens with MIC 8 mg/L, ceftriaxone 2 grams maintains free drug concentrations above the MIC for 17.7 hours (range 13.3-22.0 hours) after the first dose. 2
If the interdialysis interval extends to 72 hours, ceftriaxone 2 grams is strongly recommended, as 1 gram may result in subtherapeutic concentrations (median 0.63 mg/L at 72 hours). 2
Critical Timing Considerations
Ceftriaxone should be administered immediately after dialysis is completed, not before or during the session, to avoid unnecessary drug removal. 2, 5, 6
The hemodialysis clearance of ceftriaxone is 26-30 mL/min/m² dialyzer area, which is clinically significant but does not necessitate supplemental dosing if the post-dialysis dose is adequate. 6
Special Populations
Patients with Concurrent Hepatic Dysfunction
In dialysis patients with both severe renal and hepatic dysfunction, limit ceftriaxone to a maximum of 2 grams daily and monitor plasma concentrations, as individual variability in clearance can occur even with apparently normal hepatic function. 1, 3
Plasma ceftriaxone concentrations should be monitored in dialysis patients to determine whether dosage adjustments are necessary, as the elimination half-life is substantially prolonged in a small percentage of patients with end-stage renal disease. 4
Meningitis or CNS Infections
For bacterial meningitis in dialysis patients, administer ceftriaxone 2 grams IV every 12 hours (total 4 grams daily) regardless of dialysis schedule, as twice-daily dosing is essential to maintain therapeutic CSF concentrations. 7, 8, 9
The standard meningitis dosing regimen takes precedence over renal dosing adjustments, as CSF penetration and sustained concentrations are critical for CNS infections. 7, 8
Common Pitfalls to Avoid
Do not reduce the ceftriaxone dose below 1 gram in dialysis patients based solely on renal impairment, as the prolonged half-life compensates for decreased clearance and maintains therapeutic concentrations. 2, 4
Do not administer supplemental doses after hemodialysis sessions if the standard post-dialysis dose has already been given, as this leads to unnecessary drug accumulation. 1, 6
Do not use once-daily 1 gram dosing if the interdialysis interval will exceed 48 hours or if treating severe infections, as this risks subtherapeutic concentrations. 2
Ensure adequate hydration in dialysis patients receiving ceftriaxone to reduce the risk of urolithiasis from ceftriaxone-calcium precipitates. 1
Monitoring Parameters
Monitor for signs of gallbladder pseudolithiasis and urolithiasis, which can occur with ceftriaxone use, particularly in patients receiving prolonged therapy. 1
Monitor prothrombin time during ceftriaxone treatment in dialysis patients with impaired vitamin K synthesis or low vitamin K stores, as alterations in coagulation parameters have been reported. 1